All News AbbVie Inc.

Equities

ABBV

US00287Y1091

Market Closed - Nyse Other stock markets 04:05:15 2024-05-31 pm EDT			5-day change	1st Jan Change
161.2 ^USD	+3.15%		+2.66%	+4.05%

May. 31	Sector Update: Health Care Stocks Flat to Higher Pre-Bell Friday	MT
May. 31	AbbVie Receives European Medicine Agency Committee's Recommendation for Approval of Severe Bowel Disease Drug Candidate	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Flat to Higher Pre-Bell Friday	May. 31	MT
AbbVie Receives European Medicine Agency Committee's Recommendation for Approval of Severe Bowel Disease Drug Candidate	May. 31	MT
AbbVie Receives Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis	May. 31	PR
AbbVie Receives Positive CHMP Opinion for Risankizumab for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis	May. 31	CI
OSE Immuno: towards an evolution of the Board of Directors	May. 30	CF
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results	May. 29	AQ
AbbVie Completes Acquisition of Landos Biopharma	May. 23	MT
AbbVie Inc. completed the acquisition of Landos Biopharma, Inc. from a group of shareholders.	May. 22	CI
Strides Pharma Arm Gets US FDA's Approval for Generic Stomach Ulcer Drug	May. 22	MT
BaseLaunch announced that it has received funding from AbbVie Inc.	May. 21	CI
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation	May. 21	AQ
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week	May. 20	AQ
Cantor Fitzgerald Initiates AbbVie at Overweight Rating With $200 Price Target	May. 17	MT
ANALYST RECOMMENDATIONS : Walmart, Netflix, Abbvie, Delta...	May. 17
Transcript : AbbVie Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 10:40 AM	May. 15
Medincell: share price falls after disappointing clinical study	May. 15	CF
AbbVie, Gilgamesh Pharmaceuticals Partner to Develop Therapies for Psychiatric Disorders	May. 13	MT
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders	May. 13	PR
Medincell: share price rises on resumption of trading	May. 09	CF
Declaration of Voting Results of the AbbVie Inc	May. 08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News AbbVie Inc.

Equities

ABBV

US00287Y1091

All News

Filters